NEUROSENSE THERAPEUTICS LTD (NRSN)
IL0011809592 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to NRSN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.65. This target is 497.66% above the current price.
NRSN was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NRSN.
In the previous month the buy percentage consensus was at a similar level.
NRSN was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-16 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-07-17 | Alliance Global Partners | Initiate | Buy |
| 2022-01-07 | Maxim Group | Initiate | Buy |